InVitria
PrivateLast Round
Grant
Oct 23, 2017
Total Funding Raised
$9.45M
Company Overview
InVitria is a biotechnology company that develops and manufactures recombinant, animal-origin-free proteins for biopharmaceutical manufacturing and formulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InVitria Comparables
Compare InVitria with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Levprot Bioscience | 71% | |
| Cape Bio Pharms | 69% | |
| MarraBio | 46% | |
InVitria Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2017 | ||||
| Grant | Jun 4, 2012 | ||||
| Convertible Debt | Jun 1, 2011 | ||||
| Grant | Aug 14, 2009 |
InVitria Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Kansas Bioscience Authority | Convertible Debt, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors increased 65% MoM, reaching 5.7K.
- Jun 1, 2025
Monthly visitors increased 80% MoM, from 4.1K to 7.4K.
InVitria Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |